Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study
Top Cited Papers
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 45 (5), 712-719
- https://doi.org/10.1016/j.jacc.2004.10.068
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) studyJournal of the American College of Cardiology, 2005
- Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With AtenololCirculation, 2004
- Renin-Angiotensin System Gene Polymorphisms and Atrial FibrillationCirculation, 2004
- Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus AtenololCirculation, 2003
- The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: Changes over three decadesJournal of the American College of Cardiology, 2003
- Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular DysfunctionCirculation, 2003
- Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial FibrillationCirculation, 2002
- Correlates of Left Atrial Size in Hypertensive Patients With Left Ventricular HypertrophyHypertension, 2002
- Impact of Different Partition Values on Prevalences of Left Ventricular Hypertrophy and Concentric Geometry in a Large Hypertensive PopulationHypertension, 2000
- Characteristics of 9194 Patients With Left Ventricular HypertrophyHypertension, 1998